Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Awareness, Care & Treatment in Obesity Management (ACTION) Study (ACTION)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03223493
Recruitment Status : Completed
First Posted : July 21, 2017
Last Update Posted : July 19, 2019
Sponsor:
Information provided by (Responsible Party):
Novo Nordisk A/S

Brief Summary:
The ACTION (Awareness, Care, and Treatment In Obesity management) study aims to identify perceptions, attitudes, behaviours, and potential barriers to effective obesity care across three respondent types: 1) People with Obesity, 2) Healthcare Providers and 3) Employer Representatives in the US. Data is collected via online surveys using a cross-sectional, US-based stratified sample design.

Condition or disease Intervention/treatment
Metabolism and Nutrition Disorder Obesity Other: No treatment given

Layout table for study information
Study Type : Observational
Actual Enrollment : 3767 participants
Observational Model: Ecologic or Community
Time Perspective: Cross-Sectional
Official Title: Awareness, Care & Treatment in Obesity Management (ACTION) Study
Actual Study Start Date : October 29, 2015
Actual Primary Completion Date : November 12, 2015
Actual Study Completion Date : November 12, 2015

Group/Cohort Intervention/treatment
People with Obesity
General population, respondents are recruited via email and/or phone through an online panel company with which respondents have provided permission to be contacted for research
Other: No treatment given
Completion of a questionnaire

Healthcare Providers
Health care professionals, respondents will be recruited via email, USPS mail, and/or phone through an online panel company with which respondents have provided permission to be contacted for research purposes or through the AMA Masterfile
Other: No treatment given
Completion of a questionnaire

Employer representatives
Employers, respondents will be recruited via email, USPS mail, and/or phone through an online panel company with which respondents have provided permission to be contacted for research purposes
Other: No treatment given
Completion of a questionnaire




Primary Outcome Measures :
  1. Awareness with the care and management of obesity among people with obesity [ Time Frame: Start of interviews day 1 until day 15 ]
    Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design

  2. Awareness with the care and management of obesity among health care providers [ Time Frame: Start of interviews day 1 until day 15 ]
    Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design

  3. Awareness with the care and management of obesity among employer representatives [ Time Frame: Start of interviews day 1 until day 15 ]
    Data is collected via online questionnaires using a cross-sectional, US-based stratified sample design



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Criteria

Inclusion Criteria:

  • GENERAL POPULATION
  • Agrees to AE reporting
  • Age at least 18 years
  • Lives in the US
  • Current BMI at least 30 kg/sqm
  • HEALTH CARE PROFESSIONALS
  • Agrees to AE reporting
  • Physician and board certified or NP/PA
  • Facility located in the U.S. and not Vermont
  • Spends at least 70% of time in direct patient care
  • Seen at least 100 patients in past month
  • Seen at least 10 patients in past month needing weight management
  • In practice 2-35 years
  • Not competitively employed
  • Primary Care Providers
  • Specialty is FP, IM, GP
  • Less than 50% patients seen for obesity
  • Obesity Specialists
  • Obesity medicine or weight loss specialist or at least 50% of patients seen for obesity
  • In practice 2-35 years
  • EMPLOYERS
  • Age at least 18 years
  • Works in the US
  • Director, Administrator, CHRO, VP or other title
  • Responsible for making or influencing decisions about health insurance or health and wellness programs
  • Company employs 500 or more full-time employees
  • Believes there is a weight issue at their company
  • Not competitively employed

Exclusion Criteria:

- None


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03223493


Locations
Layout table for location information
United States, New York
Novo Nordisk Investigational Site
Honeoye Falls, New York, United States, 14472
Sponsors and Collaborators
Novo Nordisk A/S
Publications of Results:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Layout table for additonal information
Responsible Party: Novo Nordisk A/S
ClinicalTrials.gov Identifier: NCT03223493    
Other Study ID Numbers: INS-4409
U1111-1198-9657 ( Other Identifier: World Health Organization (WHO) )
First Posted: July 21, 2017    Key Record Dates
Last Update Posted: July 19, 2019
Last Verified: July 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Yes
Plan Description: According to the Novo Nordisk disclosure commitment on novonordisk-trials.com

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity
Nutrition Disorders
Overnutrition
Overweight
Body Weight
Signs and Symptoms